{
    "eid": "2-s2.0-85133959611",
    "title": "Incidence of oxaliplatin hypersensitivity reaction among colorectal cancer patients: A 5-year retrospective study",
    "cover-date": "2022-04-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Pharmacy",
            "@code": "3611",
            "@abbrev": "HEAL"
        },
        {
            "@_fa": "true",
            "$": "Pharmaceutical Science",
            "@code": "3003",
            "@abbrev": "PHAR"
        }
    ],
    "keywords": [
        "Colorectal cancer",
        "Hypersensitivity reactions",
        "Oxaliplatin",
        "Risk factors"
    ],
    "authors": [
        "Sirinoot Palapinyo",
        "Jettanong Klaewsongkram",
        "Virote Sriuranpong",
        "Nutthada Areepium"
    ],
    "citedby-count": 1,
    "ref-count": 31,
    "ref-list": [
        "Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors",
        "Colon Cancer, Version 2. 2021, NCCN Clinical Practice Guidelines in Oncology",
        "Current Colorectal Cancer in Thailand",
        "Real-World Effectiveness of Adjuvant Oxaliplatin Chemotherapy in Stage III Colon Cancer: A Controlled Interrupted Time Series Analysis",
        "Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO-ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS",
        "Oxaliplatin",
        "Oxaliplatin/fluorouracil-based adjuvant chemotherapy for locally advanced rectal cancer after neoadjuvant chemoradiotherapy and surgery: a systematic review and meta-analysis of randomized controlled trials",
        "NCCN Guidelines Insights: Colon Cancer, Version 2.2018",
        "Adjuvant Chemotherapy Using the FOLFOX Regimen in Colon Cancer",
        "Diagnosis and management of hypersensitivity reactions related to common cancer chemotherapy agents",
        "Platinum Chemotherapy Hypersensitivity: Prevalence and Management",
        "A retrospective analysis of the risk factors for allergic reactions induced by the administration of oxaliplatin",
        "Comparison between hypersensitivity reactions to cycles of modified FOLFOX6 and XELOX therapies in patients with colorectal cancer",
        "Hypersensitivity reactions to oxaliplatin: clinical features and risk factors in Koreans",
        "Safety profile of oxaliplatin in 3,687 patients with cancer in China: A post-marketing surveillance study",
        "Oxaliplatin-free interval as a risk factor for hypersensitivity reaction among colorectal cancer patients treated with FOLFOX",
        "Hypersensitivity to Oxaliplatin: An Investigation of Incidence and Risk Factors, and Literature Review",
        "Risk factors for oxaliplatin-induced hypersensitivity reactions in Japanese patients with advanced colorectal cancer",
        "Hypersensitivity to oxaliplatin: clinical features and risk factors",
        "Performance Status Assessment by Using ECOG (Eastern Cooperative Oncology Group) Score for Cancer Patients by Oncology Healthcare Professionals",
        "Allergic reactions to oxaliplatin in a single institute in Japan",
        "Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon canceEngl",
        "Desensitization for drug allergy",
        "Hypersensitivity Reactions Associated with Platinum Antineoplastic Agents: A Systematic Review",
        "Hypersensitivity Reactions to Oxaliplatin: Identifying the Risk Factors and Judging thEfficacy of a Desensitization Protocol",
        "Eosinophilic Drug Allergy",
        "Oxaliplatin-induced allergic reaction in patients with colorectal cancer in Japan",
        "Immune Dysfunction as a Cause and Consequence of Malnutrition",
        "Hypoalbuminemia: Pathogenesis and Clinical Significance",
        "Factors Influencing the Appearance of Oxaliplatin-Induced Allergy"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}